Anticancer Bioscience's Dun Yang, PhD Has Been Named as a 20

nticancer Bioscience (ACB), pioneers in synthetic lethal approaches to precision oncology, is delighted to announce that their Founder, President and CEO, Dun Yang, PhD has been named as a 2022 In Vivo Rising Leader.

Related Keywords

Chengdu , Sichuan , China , Australia , United States , India , United Kingdom , California , San Francisco , J Michael Bishop , Sue Charles , University Of California , Scius Communications , J Michael Bishop Institute Of Cancer Research , Tianfu International Biotown , Columbia University , Anticancer Bioscience , Dun Yang , Vivo Rising , Bishop Institute , Cancer Research , Resume , Careers , Nticancer Biosciences Dun Yang , Hd Has Been Named Asa 2022 In Vivo Rising Leader , Iospace , Advice ,